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Abstract
Objective—Brain enlargement has been observed in individuals with autism as early as two
years of age. Studies using head circumference suggest that brain enlargement is a postnatal event
that occurs around the latter part of the first year. To date, no brain imaging studies have
systematically examined the period prior to age two. In this study we examine MRI brain volume
in six month olds at high familial risk for autism.
Method—The Infant Brain Imaging Study (IBIS) is a longitudinal imaging study of infants at
high risk for autism. This cross-sectional analysis examines brain volumes at six months of age, in
high risk infants (N=98) in comparison to infants without family members with autism (low risk)
(N=36). MRI scans are also examined for radiologic abnormalities.
Results—No group differences were observed for intracranial cerebrum, cerebellum, lateral
ventricle volumes, or head circumference.
Conclusions—We did not observe significant group differences for head circumference, brain
volume, or abnormalities of radiologic findings in a sample of 6 month old infants at high-risk for
autism. We are unable to conclude that these changes are not present in infants who later go on to
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receive a diagnosis of autism, but rather that they were not detected in a large group at high
familial risk. Future longitudinal studies of the IBIS sample will examine whether brain volume
may differ in those infants who go onto develop autism, estimating that approximately 20% of this




Multiple lines of converging evidence (from post-mortem, magnetic resonance imaging, and
head circumference studies) have documented brain and head size enlargement in autism
spectrum disorders (ASDs) (1–10). Brain MRI studies have revealed generalized
enlargement in cerebral cortical gray and white matter (9–11), and selected subcortical
structures (12) that are present as early as 2 years of age. A longitudinal MRI study of two
year old children with ASDs followed up at 4–5 years of age, demonstrating enlargement at
age two with no increase in growth rate during the subsequent two year interval, was
consistent with the conclusion that increased brain volume is the result of overgrowth
occurring prior to 2 years of age (10). A recent report on a sample of 2–50 year olds with
ASDs (13) has also noted early brain enlargement associated with autism, characterized by
an early postnatal period of overgrowth followed by a period of slower or arrested growth.
Longitudinal head circumference studies suggest the onset of brain overgrowth is in the later
part of the first year of life (9, 14), and higher rates of macrocephaly has been observed in
parents of probands with ASD (7). Data from behavioral studies of infant siblings of autistic
individuals (infant siblings who are therefore at high genetic risk for developing an ASDs)
suggest that most of the defining features of this condition (e.g., social deficits) are not
present at 6 months of age, but are first evident by 12 months of age (15). These two
independent lines of research (brain studies, developmental behavioral studies) appear to
converge on the latter part of the first year of life as a period of both changes in brain
structure and the onset of behavioral symptoms of autism.
Structural imaging studies of early brain development in typically developing children
highlight that the first year of life is a time of dynamic growth, where total brain volume
increases 100% (16). As autism is not typically diagnosed until about age two years or later,
studies of abnormal brain development during infancy in autism must wait until the
diagnosis is examined at a later date before reaching conclusions about early brain
abnormalities associated with this disorder. Given the high recurrence risk of autism in
subsequently born siblings (17), a strategy that has recently been employed is the
examination of the infant siblings of autistic children (i.e., infants at risk for autism prior to
the diagnosis of autism). Virtually nothing is known about early brain development in
infants at risk for autism from neuroimaging studies, including whether there are observable
differences in brain volume compared to infants with no known genetic risk for autism (i.e.,
referred to here as ‘low risk’ subjects who are drawn from the normal population and
therefore most often displaying typical development).
The present study reports on volumetric brain MRI measures in a large sample of six month
old infants at high genetic risk for autism in comparison to a sample of infants at low risk for
autism. The current report is the first to focus on measuring brain volume in six month olds
at high familial risk for autism, where approximately 20% may receive a later diagnosis of
an ASD, to test whether brain volume differences may be associated with high risk for ASD.
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This study includes data acquired from an NIH-funded Autism Center of Excellence (ACE)
network study. Informally called the Infant Brain Imaging Study (IBIS), the network
includes four clinical data collection sites (University of North Carolina at Chapel Hill,
University of Washington, Children’s Hospital of Philadelphia, Washington University in
St. Louis, a Data Coordinating Center at the Montreal Neurological Institute at McGill
University, and two image processing sites (University of Utah and UNC). This ACE
Network study is currently ongoing and collecting neuroimaging and behavioral data on
infants who are at genetic risk for ASDs by virtue of having an older sibling with autism
(referred to as ‘high risk sibs’), with the following design: (1) enroll six month old infants,
who are at high genetic risk for autism, to be seen for follow-up assessments at 12 and 24
months of age; (2) enroll high-risk infant sibs who enter the study at 12 months of age and
are followed up at 24 months; and (3) enroll a comparison group of typically-developing
controls considered to be at low risk for autism (i.e., older sibling is typically developing)
seen at 6, 12 and 24 months. Diagnostic outcome data for ASD status is determined at 24
months of age (and again at 36 months of age, depending when the subjects can be seen
within the timeline of the project). For the purposes of this paper, we have included cross-
sectional data on the six month olds who were scanned from the start of the study through
the fall of 2010. Two groups were included: infants at high risk for autism (HR) and
typically-developing children considered to be at low-risk for autism (LR). Subjects were
combined from all four clinical data collections sites.
The subjects in this sample include all children with imaging data collected and processed
thru 9/30/10. There were 318 children who attempted the MRI scans, and 88% HR and 83%
LR subjects were successfully scanned, for a total of 276 scans. Due to difficulties in
scheduling visits, missed visits (e.g., due to illness, changes in travel plans), some children
seen in a wider age window up to 8 months of age. Infants develop rapidly during the first
year, and so for the purpose of this analysis, a narrow ‘optimal’ age window was defined as
6 months of age −1 week/+ 3 weeks. There were 134 infants who were in this optimal age
window (98 HR and 36 LR) and all results presented below are based on this sample. Of
note, the wider age group around the first time point will be included in later longitudinal
analyses of these data.
Subjects were characterized as HR if they had an older sibling with a diagnosis of an ASD
that was documented in a clinical diagnostic report and confirmed by an Autism Diagnostic
Interview (ADI-R) administered at enrollment. Subjects were enrolled in the LR group if
they had an older sibling without evidence of ASDs and no family history of a first or
second-degree relative with ASDs. Exclusion criteria for both groups included the
following: (1) diagnosis or physical signs strongly suggestive of a genetic condition or
syndrome (e.g., fragile X syndrome) reported to be associated with ASDs, (2) a significant
medical or neurological condition affecting growth, development or cognition (e.g., CNS
infection, seizure disorder, congenital heart disease), (3) sensory impairment such as vision
or hearing loss, (4) low birth weight (<2000 grams) or prematurity (<36 weeks gestation),
(5) possible perinatal brain injury from exposure to in-utero exogenous compounds reported
to likely affect brain adversely in at least some individuals (e.g., alcohol, selected
prescription medications), (6) non-English speaking families, (7) contraindication for MRI
(e.g., metal implants), (8) adopted subjects, and (9) a family history of intellectual disability,
psychosis, schizophrenia or bipolar disorder in a first-degree relative.
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Behavioral assessment—Infants are assessed directly at ages 6, 12 and 24 months and a
phone interview is conducted with parents at 18 months to assess infant development. Direct
assessments include brain MRI scans in addition to a battery of behavioral and
developmental tests. The assessment battery for the visit at 6 months included the Mullen
Scales of Early Learning (Mullen) (18), the Vineland Adaptive Behavior Scales-II (19), the
Autism Observation Scale for Infants (20), various questionnaires examining behavior,
temperament, and family characteristics, and a medical record review. See Table 1 for a
description of subject characteristics.
MRI acquisition—All the brain MRI scans were completed at each of the clinical sites on
a 3T Siemens Tim Trio scanner with a 12-channel head coil. All scans were completed
while infants were naturally sleeping. Specific structured preparation was completed by
families at home prior to the scanning, including conditioning to the scanner sounds on a CD
played to infants while sleeping. The imaging protocol was designed to maximize tissue
contrast for volumetric analysis across three timepoints (ages 6, 12, 24 months). The
protocol included (1) a localizer scan, (2) 3D T1 MPRAGE: TR=2400ms, TE=3.16ms, 160
sagittal slices, FOV=256, voxel size = 1mm3, (3) 3D T2 FSE TR=3200ms, TE=499ms, 160
sagittal slices, FOV=256, voxel size = 1mm3, and (4) a 25 direction DTI: TR=12800ms,
TE=102ms, slice thickness = 2mm isotropic, variable b value = maximum of 1000s/mm2, ,
FOV=190.
A number of quality control procedures were employed to assess scanner stability and
reliability across sites, time, and procedures. A ‘LEGO’ phantom (21) was scanned monthly
at each location and analyzed for image quality (22) and to quantitatively address site
specific regional distortions. Two adult subjects (aka ‘human phantoms’) were scanned once
per year per scanner (twice in year 1). Phantom data was evaluated for scanner stability
across sites and time (23, 24). Results indicated excellent stability across sites, with
covariates of variation for intracranial volume below 1%, and with intraclass correlations for
intracranial volume at 0.98 for inter-site and 0.99 for intra-site reliability. Finally, all scans
were blindly reviewed for image quality by a single rater (D. Louis Collins, McGill), and
again rated by a single reviewer (Rachel Gimpel Smith, UNC) in a pre-processing stage
prior to image analysis.
Radiologic Review—All scans were reviewed locally by a pediatric neuroradiologist for
radiologic findings that, if present, could be communicated to the participants. In addition, a
board certified pediatric neuroradiologist (R.C.M., Washington University) blindly reviewed
all MRI scans across the IBIS network and rated the incidental findings. A third
neuroradiologist (D.W.W.S., University of Washington) provided a second blind review for
the Washington University site, and contributed to a final consensus rating if there were
discrepancies between the local site reviews and the network review. The final consensus
review was used to evaluate whether there were group differences in the number and/or type
of incidental findings.
Image Processing—The following brain volumes were obtained: intracranial volume
(ICV), total brain volume = gray matter (GM) plus white matter (WM), total cerebrospinal
fluid (CSF), cerebrum, cerebellum, and lateral ventricles. There is limited tissue contrast in
the 6 month old brain due to ongoing myelination and maturation. As a result of the
resulting reduced MRI tissue contrast at that age, reliable separation of WM and GM tissue
is highly limited. Thus, we chose to initially focus on the total brain volume measure
without separating WM and GM. We also parcellated the brain into large regions (e.g.,
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cerebrum, cerebellum, hemispheres) but omitted a fine-grained lobar or cortical
segmentation which is less reliable at this young age.
The brain volume segmentations were obtained following a rigid transformation to a
normative brain space and pre-processing for bias correction and intensity normalization.
These steps are part of the expectation-maximization (EM) tissue segmentation method (25)
via the AutoSeg tool (26). Tissue probability maps for WM, GM, and CSF were obtained.
ICV was defined to be the sum of WM, GM, and CSF and an example of the segmentation
label is shown in Figure 1.
Measures of head circumference were obtained using a semi-automated image processing
tools using an established protocol (9). Head circumference was measured by a single rater
using the HeadCirc tool developed by collaborators at UNC, which computes head
circumference by extracting the appropriate contour from head segmentation of MRI (using
Fourier harmonics to parameterize the contour of the head on MRI). Intra- and inter-rater
reliability for the head circumference measures on the six month old dataset was exceptional
(ICC = .99 for each). The ITK-SNAP tool (27) was used by a single rater to obtain
measurement of the lateral ventricles. Intra- and inter-rater reliability for the lateral
ventricles was ICC = .99 (this was true for combined volume, and right/left hemisphere).
AutoSeg, HeadCirc and ITK-SNAP tools are available at http://www.ia.unc.edu/dev/
download and http://www.nitrc.org.
There were 12 total cases that were excluded based on failing to pass the initial scan review
and/or pre-processing steps. Failures included misaligned images (2), off-center/distortions
(2), registration (3), or poor image quality/artifact (5). There were no group differences in
the rate or type of failures.
Statistical Analysis
Power Consideration—The design of the study was based on findings from our previous
examination of 2–4 year olds with ASD compared to TYP controls (10). Percent increase in
the volume of relevant structures (e.g., cerebral cortex, cerebral cortical WM and temporal
lobe WM) has been reported to range from 4 to 9% with effect size Cohen’s d from 0.59 to
0.95 in cross-sectional samples of 45–51 cases versus 15–26 controls. With our current
sample size of 36 LR and 98 HR, we are expecting to have 85% −99% power to identify the
similar effect size as observed in the sample of 2–4 year old children with ASD.
Analysis—Our research question was to examine whether there were significant group
differences in head circumference, brain volumes, and radiologic findings in a group of
infants at high genetic risk for autism. Group differences were tested with Fisher exact test
in sex, and separate ANOVA models were used for group differences in Mullen ELC,
gestational age at birth, age at MRI scan, and maternal age at birth while controlling for site
differences. Cross-sectional group difference in brain volumes were analyzed using a
General Linear Model (GLM) in SAS. Covariates included in the model were age at scan,
sex (male/female), site, and the Mullen Early Learning Composite standard score.
Dependent variables of interest included Intracranial Volume (ICV), Total Tissue (GM
+WM), Cerebral Spinal Fluid (CSF), Cerebrum (left/right, total tissue+CSF), Cerebellum
(left/right, total tissue+CSF), head circumference, and lateral ventricles (left/right). To test
the potential sex differences on group effect, the additional interaction term (Group X Sex)
was included in the model.
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There were no significant group differences for age (p=.37), sex (p=.69), Mullen Early
Learning Composite standard score (p=.13), gestational age (p=.47), maternal age at
childbirth (p=.37), or SES (p=.76), as measured by parental report of family income. There
was a significant difference between groups in level of maternal education (p=.01), with the
HR group containing more college educated mothers (42% compared to 22% LR). However,
it was also noted that the LR group had a higher rate of mothers with graduate degrees (42%
compared to 18% HR).
Radiologic Reviews
Scans were rated as either normal, abnormal, or noted with incidental findings. One child
was excluded from the study for a radiologic abnormality (Chiari I malformation = 5mm). In
the HR group, 44% of scans were read as normal and 56% with incidental findings. The LR
group had 39% read as normal and 61% with incidental findings. There were no differences
observed between the HR and LR groups in proportion of these scans (Chi-Square = .27, 1
DF, p=.60).
Types of incidental findings observed included: enlargement of perivascular spaces (PVS)
(LR=4, 11%; HR=5, 5%), enlargement of subarachnoid spaces(SAS) (LR=17, 47%; HR=49,
50%), Chiari I malformation < 5mm (LR=1, 3%), pineal cyst (LR=1, 3%), cavum septum
pellucidum (LR=1, 3%), plagiocephaly (LR=1, 3%), cavum velum interpositum (HR= 2,
2%), and pars intermedia cyst of the pituitary (HR=1, 1%). There were 6 HR (6%) and 3 LR
(8%) cases who had more than 1 atypicality observed (included in the list above). Specific
ratings were given to the PVS (0,1, or 2) and SAS (0,1,2, or 3) to indicate the degree/
severity of enlargement so that groups could be compared on the size of perivascular and
subarachnoid space enlargement. See Figure 2. No group differences in the degree of SAS
enlargement (Chi-Square = 3.1, DF=3, p=.37) or increase in PVS (Chi-Square = 2.5, DF=2,
p=.29) were found.
Head Circumference
After adjusting for age and site, HR and LR groups did not differ in head circumference (p=.
55). Mean head circumference for the HR group was 44.5 cm (SD 1.41) and for the LR
group was 44.6 cm (SD 1.34). There were no group X sex differences in head circumference
(p=.36). See boxplot in Figure 3 and scatterplot in Figure 4.
Total brain volume (ICV), Total Tissue, CSF
There were no significant differences between the HR and LR groups for any of the global
measures of brain volume after adjusting for age, sex, site, and cognitive development.
There were no significant group differences in total brain volume (ICV), total tissue, or total
CSF (see Table 2 for mean volumes and comparisons). Boxplots displaying ICV and total
tissue for cerebrum and cerebellum for the HR and LR subjects is displayed in Figure 3. A
scatterplot for ICV is shown in Figure 4.
Cerebral cortex/Cerebellum
Total tissue volume (GM+WM) and total CSF volume for the cerebrum and cerebellum
were examined, as well for each hemisphere (right/left) of the cerebrum and cerebellum. The
groups did not differ significantly in any of the measures, and there were no significant
group X sex effects. Mean group volumes for these measures are displayed in Table 2.
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Volume of the lateral ventricles was compared between groups for left and right ventricle
and group means are presented in Table 2. There were no group differences for either left or
right ventricular volume, or when examining group X sex effects (left p=.80, right p=.46).
Discussion
First degree relatives of autistic individuals are reported to have high rates of macrocephaly
(6). In addition, it is anticipated that approximately 20% of HR infants in this sample will
meet criteria for an autism spectrum disorder by 36 months of age (17). In this first report of
brain volume in 6 month old infants at high familial risk for autism from an ongoing
longitudinal neuroimaging study, we find no differences in overall brain tissue volumes,
head circumference, or ventricular volumes compared to LR peers.
This investigation does not address the question as to whether early brain volume
differences can be observed in those HR children who are later diagnosed with an ASD,
which will be examined in the longitudinal dataset from this study. Rather our intent was to
study whether differences in brain volume could be detected in a sample of children at high
genetic risk for autism, an approach that has been used previously to examine familial rates
of macrocephaly in ASD (7). There is, therefore, a chance that using outcome data we will
be able to detect significant differences at 6 months once we are able to examine trajectories
of growth in the various subgroups at 24 months of age.
The absence of brain volume differences in six month olds at high familial risk for autism in
this large cohort is consistent with our hypothesis that brain enlargement in autism as well as
possibly in those with high genetic liability is a later occurring post-natal process.
Disruptions of cortical maturation related to impaired experience-dependent synaptic
development have been observed in mouse models of both Angelman Syndrome (28) and
Fragile X syndrome (29), neurogenetic developmental disorders that have behavioral
features which overlap with ASDs. There is also the report of mutations associated with the
defective expression of activity-driven genes in individuals with ASDs (30), although it is
unclear whether this mechanism accounts for more than a very small proportion of genetic
variance underlying ASDs. Other hypotheses about brain overgrowth, based on the
observation that early brain overgrowth is associated with increases in cortical surface area
(10), suggest that brain overgrowth in the latter part of the first year may be the result of an
increase in neuronal precursors, perhaps related to aberrant molecular regulatory processes
(31). The findings from the current study suggest that early postnatal events may underlie
latter occurring brain overgrowth and raise the optimistic possibility that there is a window
of opportunity where early postnatal intervention, during a period of tremendous brain
plasticity, may have an important impact on later emergence of autistic behavior.
Studies examining early behavioral markers of autism have shown infants who later go on to
receive a diagnosis of an ASDs do not exhibit overt autistic behaviors at 6 months of age
(15, 17). However, by 12 months of age, a time when we anticipate brain differences may
begin to emerge, behavioral deficits can be detected in those infants who are later diagnosed
with autism (15, 17, 32). Work by our group examining the behavioral characteristics of our
sample is underway. In the current study, the HR group likely includes children who later
receive a diagnosis of autism. With the later addition of diagnostic outcome data on this
sample, it will be possible to examine whether brain volumes for those children who are HR
and eventually manifest ASDs differ from those HR children who do not go on to develop
ASDs, to specifically test our hypothesis of brain overgrowth in the latter part of the first
year of life or early second year of life.
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We also did not detect any clinically significant radiologic findings specific to the HR
group. The types and rate of incidental findings observed was the same between groups, as
was the degree of enlargement for the subarachnoid spaces and the periventricular spaces.
Most reports looking for evidence of clinical neuroradiologic abnormalities in individuals
with autism have not detected a significant type or pattern of findings associated with the
disorder. Scattered reports of individuals with neuronal migration abnormalities (33), as well
as subcortical abnormalities in the corpus callosum (34) and increased rates of dilated
Virchow-Robin spaces (35) exist. However, numerous methodological shortcomings such as
the etiologic heterogeneity known to be inherent in autism, small sample sizes, variations in
subject age and inconsistent findings across studies have complicated interpretation of this
research. One large-scale retrospective study (36) observed elevated rates clinically reported
abnormalities in children with autism compared to medical patients. Forty-eight percent of
the ASD cases were rated as having abnormalities. The primary abnormalities observed
included white matter signal intensity abnormalities, dilated Virchow-Robin spaces, and
temporal lobe abnormalities (e.g., subcortical hyperintensities in the temporal poles). White
matter abnormalities (e.g., punctate or posterior T2 hyperintensities) were present in
younger children (e.g., 5 year olds versus 7 year olds), while the temporal lobe abnormalities
showed no developmental trend. It should be noted that the current study differs from this
report by Boddaert (36) as we do not explicitly examine children (2 to 16 years of age) with
ASDs, but rather we examine infants at high risk for autism. The developmental nature of
incidental findings we observed and their association with ASDs therefore remains a
question worthy of future investigation.
A limitation of this study, due in part to our focus on six month olds, is that, due to the
difficulty associated with segmenting gray and white matter at this early age in
development, we are unable to define regionally-specific brain volumes. White matter
structure and myelination may best be captured with other methods, such as diffusion tensor
imaging (DTI), and we have recently reported significant differences in white matter
development in HR infants who later receive a diagnosis of ASD (37). More dynamic
methods like resting state functional MRI (fcMRI) may also detect early functional changes
prior to the occurrence of more grossly observable changes in volume. These methodologies
may be more sensitive to early brain differences and may be able to detect changes in
structural or functional development that are not possible using standard tissue classification
methods. Lastly, our current study is cross-sectional and at this point our sample is
characterized in terms of HR and LR status. Only a portion of our current HR group may
later be diagnosed with an ASD. We will include diagnostic outcome data and longitudinal
imaging data from later timepoints (e.g., 12, 24 and/or 36 months of age) to examine the
groups for more specific insights into the behavioral and biological mechanisms underlying
the development of ASDs.
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Figure 1. Brain segmentation at six months of age
Figure 1 displays T1w and T2w axial MRI images of a 6 month infant are displayed in
panels 1 and 2, in panel 3 with label maps for total brain (yellow) and CSF (blue)
segmentations, and in panel 4 with a 3-D rendering of intracranial volume (ICV) (back,
blue) and brain surface (front, yellow).
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Figure 2. Grading of subarachnoid spaces (SAS) and periventricular spaces (PVS)
The image on the left demonstrates mild enlargement of the subarachnoid spaces. Minimal
enlargement is defined as one vessel width of SAS and brain that does not touch the inner
table of the calvaria on multiple consecutive sections. Mild SAS has a vessels floating in
CSF space over the convexities more than one vessel thick. Moderate enlargement of the
SAS extends to significantly enlarge the CSF space between the hemispheres along the falx
cerebri. Marked enlargement of the SAS would be profound pathological enlargement for
the CSF spaces over and between the hemispheres.
The image on the right demonstrates mild enlargement of the perivascular spaces. Minimal
enlargement of the PVS is defined as fewer than 5 small, linear T2 hyperintensities or 1–2
larger foci. Mild enlargement is 5–10 small, linear or 3–5 larger, rounded hyperintensities.
Moderate enlargement of the PVS is when there are more than 10 linear or 5–10 larger,
rounded hyperintensities. Marked enlargement of the PVS involves pathological number,
size and location (e.g., corpus callosum) of the hyperintensities associated with white matter
volume loss.
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Figure 3. Boxplots of head circumference and total brain volumes for HR and LR subjects
Figure 3 shows plots of head circumference (panel 1), intracranial volume (ICV) (panel 2),
and total tissue volumes for cerebrum (panel 3) and cerebellum (panel 4). Head
circumference is displayed in centimeters (cm) and brain volumes shown in centimeters
squared (cm3).
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Scatterplots of head circumference and intracranial volume for HR and LR subjects.
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